- Corporate Officers - G
- Gengos Andrew
Insider Trading History of Gengos Andrew
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gengos Andrew since 2015.
This trader's CIK number is 1563623.
At the time of last reporting, Gengos Andrew was the Chief Financial Officer of Terns Pharmaceuticals, Inc.. (stock ticker symbol TERN).
Also see all insider trading activities at Terns Pharmaceuticals, Inc..
Note that in the past
Gengos Andrew also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Terns Pharmaceuticals, Inc. (TERN) by Gengos Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | TERN | 25,000 | $96,365 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunocellular Therapeutics, Ltd. (IMUC) by Gengos Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | IMUC | 51,333 | $29,149 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Athira Pharma, Inc. (ATHA) by Gengos Andrew
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ATHA | 0 | $0 | 2,480 | $4,234 | 0 | $0 |
| 2023 | ATHA | 80,012 | $243,239 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Gengos Andrew:
1. Terns Pharmaceuticals, Inc. (TERN)
2. Immunocellular Therapeutics, Ltd. (IMUC)
3. Athira Pharma, Inc. (ATHA)
Table 1. Insider trading of Terns Pharmaceuticals, Inc. (TERN) by Gengos Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-27 | TERN | Buy | 10,000 | 3.93 | 39,280 |
| 2025-06-16 | TERN | Buy | 5,000 | 3.95 | 19,735 |
| 2025-06-13 | TERN | Buy | 10,000 | 3.73 | 37,350 |
Table 2. Insider trading of Immunocellular Therapeutics, Ltd. (IMUC) by Gengos Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-11-30 | IMUC | Buy | 10,000 | .43 | 4,350 |
| 2015-02-18 | IMUC | Buy | 41,333 | .60 | 24,799 |
Table 3. Insider trading of Athira Pharma, Inc. (ATHA) by Gengos Andrew
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-05 | ATHA | Sale | 1,272 | .57 | 719 |
| 2023-01-05 | ATHA | Sale | 1,208 | 2.91 | 3,515 |
| 2023-06-07 | ATHA | Buy | 15,000 | 3.40 | 50,985 |
| 2023-06-02 | ATHA | Buy | 20,012 | 2.85 | 57,074 |
| 2023-06-05 | ATHA | Buy | 45,000 | 3.00 | 135,180 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gengos Andrew
(Chief Financial Officer of Terns Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.